CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling
Top Cited Papers
Open Access
- 1 April 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (14) , 10594-10601
- https://doi.org/10.1074/jbc.m010149200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Connective Tissue Growth Factor: What's in a Name?Molecular Genetics and Metabolism, 2000
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Expression of TGF-β1, -β2 and -β3 in localized and systemic sclerodermaJournal of Dermatological Science, 1999
- Induction of Inhibitory Smad6 and Smad7 mRNA by TGF-β Family MembersBiochemical and Biophysical Research Communications, 1998
- Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-βJournal of Biological Chemistry, 1998
- Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cellsProceedings of the National Academy of Sciences, 1997
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the α1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesisJournal of Hepatology, 1991
- Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.The Journal of cell biology, 1991